Has Chelsea Roe received payments from drug or device companies?

Yes. Drug and device makers reported $3,765 in general payments to Chelsea Roe across 154 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Chelsea Roe did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Chelsea Roe come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Chelsea Roe

Family · Newport News, VANPI 1649899071

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,287 of the $3,765 with a category attached, or 87.3%. It is spread thinly across 45 manufacturers, the largest accounting for just 9.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,285 and has fallen 90.7% since, to $120 in 2025. Among family clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,765in general payments, 2019–2025

Across 154 payments — averaging $24.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$345
Pharmacyclics LLC, An Abbvie Company$295
Merck$254
AstraZeneca$248
Seagen Inc.$235
Novartis$210
plus $2K from 39 others

What the payments were for

Food & beverage$3,28787%
Education$47813%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson(2 entities)	14	$345
Pharmacyclics LLC, An Abbvie Company	13	$295
Merck	12	$254
AstraZeneca(2 entities)	8	$248
Seagen Inc.	9	$235
Novartis	9	$210
Pfizer	9	$201
Amgen	8	$163
Takeda Pharmaceuticals U.S.A., Inc.	2	$127
Sanofi	4	$110
AbbVie	1	$102
Astellas Pharma US Inc	2	$93
Incyte Corporation	4	$83
Gilead(2 entities)	4	$83
Beigene USA, Inc.	3	$83
GSK	3	$77
Puma Biotechnology, Inc.	3	$74
Bayer	4	$74
Eisai Inc.	3	$69
Taiho Oncology, Inc.	2	$64
Jazz Pharmaceuticals Inc.	2	$48
Lilly USA, LLC	3	$47
Blueprint Medicines Corporation	2	$46
Daiichi Sankyo Inc.	2	$45
Ipsen Biopharmaceuticals, Inc	2	$43
AVEO Pharmaceuticals, Inc.	2	$42
Octapharma USA, Inc.	2	$40
Myovant Sciences Inc.	2	$40
Acrotech Biopharma Inc.	2	$40
Deciphera Pharmaceuticals Inc.	2	$39
Pharmaessentia USA Corporation	1	$34
Karyopharm Therapeutics Inc.	1	$29
Immunogen, Inc.	1	$28
Coherus Oncology, Inc.	1	$25
ADC Therapeutics America, Inc.	1	$25
Servier Pharmaceuticals LLC	1	$25
Pharmacosmos Therapeutics Inc.	1	$24
Genentech USA, Inc.	2	$24
Dova Pharmaceuticals	1	$22
EMD Serono, Inc.	1	$22
Accord Healthcare, Inc.	1	$20
Bristol Myers Squibb	1	$18
E.r. Squibb & Sons, L.L.C.	1	$18
Exelixis Inc.	1	$18
Foundation Medicine, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EPKINLY$102

How this compares

$3,765 in reported general payments places this provider in the 90th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ondansetron Hcl	11	$4,512
Exemestane	17	$3,975
Letrozole	39	$938
Anastrozole	24	$646

Paid to pharmacies, not to this prescriber.

Other family in Newport News

Rosemarie McFatherNewport News$13K
Sabrina BrownNewport News$11K
Andrea CottonVirginia Beach$696K
Susan MooreWytheville$438K
Ellen WermterCharlottesville$251K
Dana StallingsFranklin$225K
Jocelyn BrackettHerndon$199K
Hochong Smith GillesRichmond$131K
Sean OlaughlinMidlothian$110K
Adam MedlinHampton$67K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →